MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹314 Cr | ₹266 Cr | ₹185 Cr | ₹236 Cr | ₹117 Cr |
What is the latest Consolidated Net Profit of MARKSANS PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹314 Cr |
Mar2023 | ₹266 Cr |
Mar2022 | ₹185 Cr |
Mar2021 | ₹236 Cr |
Mar2020 | ₹117 Cr |
How is Consolidated Net Profit of MARKSANS PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹314 Cr | 17.80 | |
Mar2023 | ₹266 Cr | 44.29 | |
Mar2022 | ₹185 Cr | -21.77 | |
Mar2021 | ₹236 Cr | 101.62 | |
Mar2020 | ₹117 Cr | - |
Compare Consolidated Net Profit of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹11,746.9 Cr | -1.1% | -14.6% | 72.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,715.0 Cr | 0.3% | -2.6% | 36.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,460.0 Cr | -1% | -0.5% | 60.8% | Stock Analytics | |
CIPLA | ₹115,271.0 Cr | -1.4% | -3.1% | 11.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,511.0 Cr | -3.8% | -4% | 15.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,189.5 Cr | 0.1% | 1.2% | 40.3% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -1.1% |
-14.6% |
72.2% |
SENSEX | -0.9% |
-4.3% |
3.7% |
You may also like the below Video Courses